Donepezil Hydrochloride Tablet, Film Coated
Product Images NDC 55111-356

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Donepezil Hydrochloride (NDC 55111-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

This is a description for Donepezil Hydrochloride Tablets USP, 5mg. Each flcoate table contains 5g onee sl Sg, with a recommended usual dosage of et arsompayingpescbing o. It should be stored at 20°C and 25°C (68-77°F) as specified by USP, and the manufacturer is Dr. Reddy's Laboratories Limited.*

FDA Label Image

Carton2 (Carton2)

FDA Label Image

Container1 (Container1)

This is a prescription for Donepezil Hydrochloride Tablets USP with a strength of 5mg. There are 30 tablets in the package. The pharmacist is advised to dispense the medication with the package insert and with the patient's safety in mind. No other meaningful information is available.*

FDA Label Image

Container2 (Container2)

Donepezil Hydrochloride Tablets USP, 10 mg, are available in a bottle containing 30 tablets. This medication is used for the treatment of dementia in patients with Alzheimer's disease. The text also includes some gibberish characters and numbers that do not contribute to the description.*

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure10 (Figure10)

FDA Label Image

Figure2 (Figure2)

This appears to be a graph or chart showing the Cumulative Percentage of Patients and their response to different dosages of Donepezil and Placebo treatment over a 10 month period in terms of change in ADAS-cog scores (a measurement of cognitive function). The graph also shows the percentage of patients experiencing no change or improvement in scores.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Figure4 (Figure4)

FDA Label Image

Figure5 (Figure5)

FDA Label Image

Figure6 (Figure6)

FDA Label Image

Figure7 (Figure7)

FDA Label Image

Figure8 (Figure8)

FDA Label Image

Figure9 (Figure9)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.